Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merit Cudkowicz

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Journal of Neurology & Neurophysiology|August 12, 2017
Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS)Sabrina Paganoni, Erin McDonnell, David Schoenfeld, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 12, 2010
A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosisNazem Atassi, Eva-Maria Ratai, David J Greenblatt, et al.
Neurology|December 15, 2015
How common are ALS plateaus and reversals?Richard S Bedlack, Timothy Vaughan, Paul Wicks, et al.
Annals of Neurology|November 6, 2004
Vitamin E intake and risk of amyotrophic lateral sclerosisAlberto Ascherio, Marc G Weisskopf, Eilis J O'reilly, et al.
Neurology|October 10, 2014
The PRO-ACT database: design, initial analyses, and predictive featuresNazem Atassi, James Berry, Amy Shui, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 10, 2013
Post-lumbar puncture headache is reduced with use of atraumatic needles in ALSColin Quinn, Erik A Macklin, Nazem Atassi, et al.
Muscle & Nerve|August 11, 2021
Gold Coast diagnostic criteria: Implications for ALS diagnosis and clinical trial enrollmentSteve Vucic, Toby A Ferguson, Catherine Cummings, et al.
The Lancet. Neurology|September 18, 2021
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trialMerit Cudkowicz, Angela Genge, Nicholas Maragakis, et al.
The Lancet. Neurology|April 6, 2010
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trialSwati P Aggarwal, Lorne Zinman, Elizabeth Simpson, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 12, 2017
Erratum to: Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment TrialRichard Smith, Erik Pioro, Kathleen Myers, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Journal of Neurology & Neurophysiology|August 12, 2017
Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS)Sabrina Paganoni, Erin McDonnell, David Schoenfeld, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 12, 2010
A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosisNazem Atassi, Eva-Maria Ratai, David J Greenblatt, et al.
Neurology|December 15, 2015
How common are ALS plateaus and reversals?Richard S Bedlack, Timothy Vaughan, Paul Wicks, et al.
Annals of Neurology|November 6, 2004
Vitamin E intake and risk of amyotrophic lateral sclerosisAlberto Ascherio, Marc G Weisskopf, Eilis J O'reilly, et al.
Neurology|October 10, 2014
The PRO-ACT database: design, initial analyses, and predictive featuresNazem Atassi, James Berry, Amy Shui, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 10, 2013
Post-lumbar puncture headache is reduced with use of atraumatic needles in ALSColin Quinn, Erik A Macklin, Nazem Atassi, et al.
Muscle & Nerve|August 11, 2021
Gold Coast diagnostic criteria: Implications for ALS diagnosis and clinical trial enrollmentSteve Vucic, Toby A Ferguson, Catherine Cummings, et al.
The Lancet. Neurology|September 18, 2021
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trialMerit Cudkowicz, Angela Genge, Nicholas Maragakis, et al.
The Lancet. Neurology|April 6, 2010
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trialSwati P Aggarwal, Lorne Zinman, Elizabeth Simpson, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 12, 2017
Erratum to: Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment TrialRichard Smith, Erik Pioro, Kathleen Myers, et al.
Pageof 12